CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 3 enrolled
Drug / intervention
MGH SECM Imaging Capsuledevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT02445014
NCT02445014N/ACompleted
CompareCT.gov

Pilot Study for Imaging of Barrett's Esophagus Using an Spectrally Encoded Confocal Microscopy Tethered Endoscopic Capsule

Massachusetts General Hospital·interventional·Posted May 15, 2015·Updated Aug 21, 2020

In Brief

A clinical study evaluating MGH SECM Imaging Capsule for Healthy and 2 related conditions. Completed, enrolled 3 participants across 1 site.

Detailed Summary

The goal of this research is to test the imaging quality of the modified, larger diameter, tethered Spectrally Encoded Confocal Microscopy (SECM) capsule in healthy subjects, subjects with Barrett's Esophagus (BE), and subjects with Gastroesophageal reflux disease (GERD).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy, Barrett's Esophagus, Gastric Acid Reflux
CountriesUnited States
CollaboratorsNational Institutes of Health (NIH), National Cancer Institute (NCI)

Timeline

N/ACompletedFinished
201520162017201820192020202120222023202420252026
First PostedMay 15, 2015
Enrollment StartDec 1, 2014
Primary CompletionJan 1, 2017
Study CompletionMar 1, 2020
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 11.1 years ago

Interventions

MGH SECM Imaging Capsuledevice

Imaging of the Esophagus using the SECM capsule and SECM Imaging system